abstract |
The present invention provides a new class of compounds for treating hyperlipidemia, obesity and impaired glucose tolerance / non-insulin dependent diabetes, obesity, hyperlipidemia and adult-onset diabetes with the compound without adversely affecting energy metabolism. It relates to a pharmaceutical composition for treatment. |